CNO Fin CNO Stock Is It a Strong Buy CNO Fin posts 206 pct EPS beat topping estimates Benf Warrant BENFW Stock Is It Near Key Zones Lockheed Martin Corporation LMT Q1 2026 Earnings TopLine Miss Mixed Operational Trends and Resilient Backlog Dynamics TVTX Travere Therapeutics beats Q4 2025 earnings expectations shares climb 338 percent on doubling yearoveryear revenue Deere Company DE Favorable Earnings Beat Metrics Ahead of Fiscal Q2 2026 Results HLXC Helix releases latest quarterly earnings outlines core strategic priorities to drive longterm business growth BXMT Blackstone Mtg posts sharp Q4 2025 EPS miss even with 121 YoY revenue growth shares fall 109 Charter Communications CHTR PreEarnings Analysis Bullish Sentiment Meets Mixed EPS Beat Odds Ahead of Q1 2026 Release Is HIVE HIVE stock attractive at current levels Steep loss delivers 423 negative EPS surprise vs consensus ECCC Eagle posts 138 percent Q4 2025 EPS beat shares remain flat in todays trading session UWM UWMC Stock What Is Driving Performance UWM posts 93 EPS miss amid mortgage margin headwinds YB Yuanbao reports 606 percent year over year Q2 2025 revenue growth shares dip 142 percent today SaverOne SVRE Stock IV Percentile 370 20260420 EVR Evercore notches strong Q4 2025 earnings and revenue gains dips 04 percent in todays trading Asana ASAN Stock AllTime High Climbs Higher 20260420 FGMCU FG Merger discloses minimal quarterly earnings data management to share strategic outlook at upcoming briefing SCCF Sachem Q4 2025 earnings vastly beat analyst expectations with shares remaining flat in regular session trading Gladstone GAING Stock Public Float At Highs 20260427 ASRV AmeriServ dips 102 after releasing Q1 2026 earnings of 011 per share with no analyst estimates available Salesforce Inc CRM Jim Cramer Issues Hold Recommendation Amid DoubleDigit YeartoDate Declines and LongTerm AI Growth Roadmap LifeMD LFMD Stock Resistance Rejection Signals Momentum Building 20260420 What does smart money think about Moderna MRNA stock 111 20260422 PLYX Polaryx Therapeutics highlights rare disease pipeline progress in its newly released quarterly earnings report